Physician profile
Gerald Robert Hamwi
NPI 1467447714
$4,187.78
in general payments reported to CMS, 2019-2025
16 companies · $943 in 2025
The $943 reported for 2025 was more than what 85% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $631 · 2021: $247 · 2022: $527 · 2023: $278 · 2024: $621 · 2025: $943.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,842.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,842.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,729.70 | 2019-2025 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $1,170.14 | 2019-2025 | Biktarvy |
| Janssen Biotech, INC. | $450.97 | 2019-2022 | |
| Napo Pharmaceuticals INC | $326.80 | 2019-2023 | Mytesi |
| Emd Serono, INC. | $112.37 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $83.78 | 2019-2020 | |
| Janssen Products, LP | $59.98 | 2020-2021 | |
| Theratechnologies INC. | $51.26 | 2019-2024 | Egrifta, Trogarzo |
| Hologic Sales and Service, LLC | $49.31 | 2023-2024 | Thinprep 2000 Processor, Aptima, Affirm Prone Biopsy System |
| Novo Nordisk INC | $33.60 | 2022-2025 | Saxenda, Wegovy |
| Glaxosmithkline, LLC. | $25.13 | 2025 | Arexvy, Shingrix |
| Galderma Laboratories, L.P. | $24.07 | 2021 | |
| Abbvie INC. | $19.74 | 2019 | |
| Lilly USA, LLC | $19.49 | 2019 | |
| Dynavax Technologies Corporation | $17.56 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $13.88 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Hamwi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.